[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 20, Issue 11 (2-2016) ::
__Armaghane Danesh__ 2016, 20(11): 1024-1035 Back to browse issues page
Association of CYP17 and SRD5A2 gene polymorphisms with Prostate cancer risk among Iranian and Indian populations
Kh Onsory 1, M Mousavi2, E Jalilvand3
1- Islamic azad university , onsory@gmail.com
2- Biology Department, Sistan-Bloochestan University, Zahedan
3- Biology Department, Faculty of Science, Damghan University, Damghan,
Abstract:   (3220 Views)

Aims and objectives: Prostate cancer is a complicated disease that genetics and environmental factors may be playing a promoting role in its progression. Polymorphism of genes such as steroid hormone receptors are having very important role in developing this disease. One such gene, CYP17 is playing role in hydroxylation and SRD5A2 gene, the predominant 5&alpha-reductase isozyme in prostate, catalyzes the conversion of testosterone into the more potent androgen, dihydrotestosterone (DHT), which is required for the normal growth and development of the prostate gland. The purpose of this study was to investigate association of CYP17 and SRD5A2 genes polymorphisms with prostate cancer risk. Materials and methods: PCR-RFLP analysis of CYP17 and SRD5A2 genes were performed on 100 prostate cancer patients admitted to the Department of Urology, Postgraduate Institute of Medical Science and Research (PGIMER), Chandigarh, India, and 150 patients from Imam Khomeini Hospital, Tehran, Iran, compared with equal number of matching controls for each group visiting same centers for other reason. The data was analyzed using the computer software SPSS for windows (version 19), using logistic regression. Results: In this case-control study, there was a significant increase with risk of prostate cancer association for individuals carrying one copy of CYP17 A2 allele in Iranian (OR= 2.10 95% CI, 1.03-4.27 P=0.041) and Indian populations (OR= 2.16 95% CI, 1.08-4.33 P=0.029). While the risk was decreased in individuals having two A2 alleles in both groups. Compared with men having the VV genotype of SRD5A2 gene, there was no significant association between the VL genotype and the risk of prostate cancer among Iranian (OR, 0.87 95% CI, 0.49 -1.56 P=0.661) and Indian (OR, 0.99 95% CI, 0.54 -1.81 P=0.989) patients. Also there was no difference in the occurrence of the genotype LL between prostate cancer patients and control groups in both studied populations therefore, there was no association between this genotype and prostate cancer risk. Conclusion: It seems to be an association between A2A2 genotype of CYP17 gene with the risk of prostate cancer but no association was found with any alleles of SRD5A2 gene with this risk.

Keywords: CYP17 and SRD5A2 genes, genetics polymorphism, prostate cancer, Iranian and Indian populations.
Full-Text [PDF 202 kb]   (907 Downloads)    
Type of Study: Research | Subject: Special
Received: 2015/11/16 | Accepted: 2016/01/20 | Published: 2016/01/23
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

onsory K, Mousavi M, Jalilvand E. Association of CYP17 and SRD5A2 gene polymorphisms with Prostate cancer risk among Iranian and Indian populations. Armaghane danesh. 2016; 20 (11) :1024-1035
URL: http://armaghanj.yums.ac.ir/article-1-1132-en.html

Volume 20, Issue 11 (2-2016) Back to browse issues page
ارمغان دانش Armaghane danesh
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4162